Page last updated: 2024-10-24

verapamil and Cancer of the Retina

verapamil has been researched along with Cancer of the Retina in 1 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abruzzo, T1
Abraham, K1
Karani, KB1
Geller, JI1
Vadivelu, S1
Racadio, JM1
Zhang, B1
Correa, ZM1

Other Studies

1 other study available for verapamil and Cancer of the Retina

ArticleYear
Correlation of Technical and Adjunctive Factors with Quantitative Tumor Reduction in Children Undergoing Selective Ophthalmic Artery Infusion Chemotherapy for Retinoblastoma.
    AJNR. American journal of neuroradiology, 2021, Volume: 42, Issue:2

    Topics: Antineoplastic Agents, Alkylating; Child; Child, Preschool; Cohort Studies; Female; Fluoroscopy; Hum

2021